Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2019-08-26 Regulatory Filings
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
Application Proof (1st submission)
Regulatory Filings Classification · 95% confidence The document is titled 'Application Proof' and contains multiple disclaimers indicating it is a draft document related to a public offering or listing on the Hong Kong Stock Exchange. It explicitly states it is not a prospectus or final listing document and is incomplete and subject to change. The content includes warnings about investment decisions, regulatory compliance, and details about the offering process, including share numbers and pricing ranges. There is no financial statement data or management discussion of financial results. The document is clearly a draft prospectus or listing application proof related to an IPO or public offering, not a financial report or earnings release. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory submission providing information about the offering but is not a final report or financial statement. The length (15,000 characters) and detailed content support this classification rather than a brief announcement or report publication announcement.
2019-08-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.